A new national study by MRI-Simmons reveals that 31% of U.S. adults have used cannabis in the past six months, confirming its place in mainstream wellness culture. As acceptance grows, cannabis is being redefined from a taboo topic to a trusted part of health and lifestyle — bringing new opportunities and challenges for businesses.

Investor confidence is rising again as Canaccord Genuity turns bullish on U.S. cannabis stocks, citing optimism over rescheduling and federal reform. Here’s why this shift matters for operators, investors, and the broader cannabis industry.

Germany’s government has approved new restrictions on online cannabis prescriptions and deliveries, aiming to curb a surge in imports after legalization. The move reflects growing regulatory oversight in global cannabis markets and signals a new phase of compliance-driven expansion.

Cannabis stocks rallied sharply after Donald Trump suggested Medicare could cover CBD in senior healthcare. While no policy has changed, the surge proves how political commentary still drives cannabis markets. Here’s what operators and investors can learn from this moment.